Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent.
Read moreFor sports fans, nothing beats seeing their favorite athletes compete at the top of their game. But a shoulder injury such as a badly torn
Read moreCommonly used medications for type 2 diabetes and obesity called glucagon like peptide-1 receptor agonists (GLP-1 RAs), are not associated with an increased risk of
Read moreShutdown orders of pretty much everything for the past year managed to shut down something plenty of guys didn’t miss: anxiety. Without events, parties, meetings,
Read moreAs mental health professionals are grappling with a wave of pandemic-related anxiety and depression, a physician-researcher at The University of Toledo College of Medicine and
Read moreA major clinical trial in Canada shows that an inexpensive anti-inflammatory drug called colchicine can significantly reduce the risk of complications and death from COVID-19,
Read moreOne day, the pandemic will end. Scientists don’t know how that finale will play out but a new model offers a teaser: The deadly SARS-CoV-2
Read moreCOVID-19 can lead to a broad range of neurologic complications including stroke, seizures, movement disorders, inflammatory diseases and more, even in moderate cases, according to
Read moreFRIDAY, Oct. 30, 2020 — Dietary supplement use is relatively common among children and adolescents, with 34 percent using any dietary supplement in the previous
Read moreA Ludwig Cancer Research study has uncovered a mechanism by which the tumor’s harsh internal environment sabotages T lymphocytes, leading cellular agents of the anticancer
Read more